NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lucida Medical

Lucida Medical

Private
CambridgeHealthcare & Life Scienceshttps://lucidamedical.com/

Last Round

Early Funding

Mar 30, 2026

Total Funding Raised

$14.72M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Lucida Medical is a healthtech company that develops artificial intelligence-based software to assist clinicians in detecting and diagnosing cancer using MRI scans.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

prostate cancer detectionmedical imaging AIradiology softwareprostate MRImedtechAI diagnosticsclinical decision supporthealthtechmedical device softwareradiology AISaaSclinical workflowAI radiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucida Medical Comps

Public and private peers based on sector, stage, and business model.

Lucida Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lucida Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 30, 2026
GrantJul 9, 2024
GrantFeb 12, 2024
SeedMar 19, 2021

Key People

Founding team and executive leadership

Antony Rix

CEO And Co-Founder

Founding Team

Mark Hinton

Chief Technology Officer

Executive Team

Lucida Medical Investors

Notable investors and investment history

Lucida Medical investors
InvestorRounds
SBRI HealthcareGrant
IW CapitalEarly Funding
Prostate Cancer ResearchSeed
NHS Accelerated Access CollaborativeGrant
XTX VenturesEarly Funding, Seed
Macmillan Cancer SupportEarly Funding, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 42% to 7,000.

  • Apr 7, 2026

    Lucida Medical is developing a patented AI software designed to support earlier and more consistent cancer detection.

Lucida Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lucida Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lucida Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range29
Year Founded2019
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.